Passa al contenuto
Merck
Tutte le immagini(1)

Documenti

27715

Sigma-Aldrich

Acido L-(+)-lattico

80%

Sinonimo/i:

Acido (S)-2-idrossipropionico, Acido sarcolattico

Autenticatiper visualizzare i prezzi riservati alla tua organizzazione & contrattuali
Tutte le immagini(1)

About This Item

Formula empirica (notazione di Hill):
C3H6O3
Numero CAS:
79-33-4
Peso molecolare:
90.08
Beilstein:
1720251
Numero MDL:
MFCD00064266
Codice UNSPSC:
12352100
ID PubChem:
57648269
NACRES:
NA.21

Livello qualitativo

100

Saggio

80%

Forma fisica

liquid

Residuo alla calcinazione

≤0.1% (as SO4)

Solubilità

water: soluble(lit.)

Anioni in tracce

chloride (Cl-): ≤50 mg/kg
sulfate (SO42-): ≤100 mg/kg

Cationi in tracce

Ca: ≤100 mg/kg
Fe: ≤10 mg/kg

Spettro attività antibiotica

Gram-negative bacteria

Modalità d’azione

cell membrane | interferes

Stringa SMILE

C[C@H](O)C(O)=O

InChI

1S/C3H6O3/c1-2(4)3(5)6/h2,4H,1H3,(H,5,6)/t2-/m0/s1
JVTAAEKCZFNVCJ-REOHCLBHSA-N

Cerchi prodotti simili? Visita Guida al confronto tra prodotti

Categorie correlate

Applicazioni


  • Pharmaceutical and biomaterial applications: L-(+)-Lactic acid enhances M2 macrophage polarization through regulation of the PCK2/AMPK/mTOR signaling pathway in poly-L-lactic acid membranes, indicating its vital role in biomedicine and materials science (Tang et al., 2024).

  • Agricultural biotechnology: The induction of defense responses in tobacco against Phytophthora nicotianae by L-(+)-Lactic acid underscores its potential application in agricultural biotechnology for plant disease management (Yan et al., 2024).



Azioni biochim/fisiol

Use as a substrate for the lactic acid dehydrogenase enzymes.

Applicazioni

N° Catalogo
Descrizione
Determinazione del prezzo

Pittogrammi

Corrosion
GHS05

Avvertenze

Danger

Indicazioni di pericolo

H314

Classi di pericolo

Eye Dam. 1 - Skin Corr. 1

Rischi supp

EUH071

Codice della classe di stoccaggio

8A - Combustible corrosive hazardous materials

Classe di pericolosità dell'acqua (WGK)

WGK 1

Punto d’infiammabilità (°F)

230.0 °F

Punto d’infiammabilità (°C)

110 °C

Dispositivi di protezione individuale

Faceshields, Gloves, Goggles, type ABEK (EN14387) respirator filter

Choose from one of the most recent versions:

Certificati d'analisi (COA)

Lot/Batch Number
STBL3141
STBK8134
STBK4532
STBK1312
STBJ6501

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Search for a COA

Possiedi già questo prodotto?

I documenti relativi ai prodotti acquistati recentemente sono disponibili nell’Archivio dei documenti.

Visita l’Archivio dei documenti

I clienti hanno visto anche

Slide 1 of 5

1 of 5

L-(+)-Lactic acid solution ~40% in H2O

Sigma-Aldrich

69780

L-(+)-Lactic acid solution

DL-Lactic acid 85 % (w/w), syrup

Sigma-Aldrich

L1250

DL-Lactic acid

Lactic acid meets USP testing specifications

Sigma-Aldrich

L6661

Lactic acid

Lactic acid Pharmaceutical Secondary Standard; Certified Reference Material

Supelco

PHR1215

Lactic acid

Lactic acid United States Pharmacopeia (USP) Reference Standard

USP

1356734

Lactic acid

Synthesis and characterization of pH-sensitive hydrogels based on chitosan and D, L-lactic acid.
Qu X, et al.
Journal of Applied Polymer Science, 74(13), 3193-3202 (1999)
Swelling and hydrolytic degradation of poly (D, L-lactic acid) in aqueous solutions.
Proikakis C S, et al.
Polymer Degradation and Stability, 91(3), 614-619 (2006)
Carlos Carmona-Fontaine et al.
Proceedings of the National Academy of Sciences of the United States of America, 114(11), 2934-2939 (2017-03-02)
The genetic and phenotypic diversity of cells within tumors is a major obstacle for cancer treatment. Because of the stochastic nature of genetic alterations, this intratumoral heterogeneity is often viewed as chaotic. Here we show that the altered metabolism of
Recovery of L-(+)-lactic acid by anion exchange resin Amberlite IRA-400.
Cao X, et al.
Biochemical Engineering Journal, 11(2), 189-196 (2002)
T Isotalo et al.
BJU international, 88(1), 30-34 (2001-07-12)
To assess whether patients in acute urinary retention from benign prostatic enlargement can be treated with a combined therapy comprising finasteride and a bioabsorbable self-reinforced poly L-lactic acid (SR-PLLA) urethral stent. Fifty-five patients in acute urinary retention were treated as
Visualizza tutti i documenti correlati

Chromatograms

application for HPLC

Il team dei nostri ricercatori vanta grande esperienza in tutte le aree della ricerca quali Life Science, scienza dei materiali, sintesi chimica, cromatografia, discipline analitiche, ecc..

Contatta l'Assistenza Tecnica.